AU2009240587A1 - Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles - Google Patents

Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles Download PDF

Info

Publication number
AU2009240587A1
AU2009240587A1 AU2009240587A AU2009240587A AU2009240587A1 AU 2009240587 A1 AU2009240587 A1 AU 2009240587A1 AU 2009240587 A AU2009240587 A AU 2009240587A AU 2009240587 A AU2009240587 A AU 2009240587A AU 2009240587 A1 AU2009240587 A1 AU 2009240587A1
Authority
AU
Australia
Prior art keywords
replikin
pathogen
cycle
virus
time period
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2009240587A
Other languages
English (en)
Inventor
Elenore S . Bogoch
Samuel Bogoch
Samuel Winston Bogoch
Anne Elenore Borsanyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2008/061336 external-priority patent/WO2008156914A2/en
Application filed by Individual filed Critical Individual
Publication of AU2009240587A1 publication Critical patent/AU2009240587A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus
AU2009240587A 2008-04-23 2009-04-23 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles Abandoned AU2009240587A1 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US12/108,458 2008-04-23
PCT/US2008/061336 WO2008156914A2 (en) 2007-05-30 2008-04-23 Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
AUPCT/US2008/061336 2008-04-23
US12/108,458 US9408902B2 (en) 2007-05-30 2008-04-23 Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
US5401008P 2008-05-16 2008-05-16
US61/054,010 2008-05-16
US8735408P 2008-08-08 2008-08-08
US61/087,354 2008-08-08
US14361809P 2009-01-09 2009-01-09
US61/143,618 2009-01-09
PCT/US2009/041565 WO2009132209A2 (en) 2008-04-23 2009-04-23 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles

Publications (1)

Publication Number Publication Date
AU2009240587A1 true AU2009240587A1 (en) 2009-10-29

Family

ID=41066049

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2009240587A Abandoned AU2009240587A1 (en) 2008-04-23 2009-04-23 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles

Country Status (6)

Country Link
EP (1) EP2300493A2 (de)
JP (1) JP2011519837A (de)
AU (1) AU2009240587A1 (de)
CA (1) CA2720465A1 (de)
IL (1) IL208765A0 (de)
WO (1) WO2009132209A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9233148B2 (en) 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
US9320784B2 (en) 2009-08-07 2016-04-26 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
WO2013151662A2 (en) 2012-03-09 2013-10-10 Samuel Bogoch Therapies, vaccines, and predictive methods for infectious salmon anemia virus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1419175B1 (de) * 2001-03-27 2011-04-27 Samuel Dr. Bogoch Replikin-peptide und anwendungen
US7189800B2 (en) * 2001-03-27 2007-03-13 Samuel Bogoch Replikin peptides in rapid replication of glioma cells and in influenza epidemics
WO2005104754A2 (en) * 2004-04-28 2005-11-10 Samuel Bogoch System and method for identifying complex patterns of amino acids
CA2598381A1 (en) * 2005-02-16 2006-08-24 Samuel Bogoch Replikin peptides and uses thereof
EP1924282B1 (de) * 2005-08-15 2017-01-11 Altimmune Inc. Immunisierung von avianen durch verabreichung von nicht-repliziert-gerichteten impfstoffen
CA2654178A1 (en) * 2006-06-16 2007-12-27 Dow Agrosciences Llc Novel dna sequences, vectors and proteins of avian influenza hemagglutinin

Also Published As

Publication number Publication date
WO2009132209A2 (en) 2009-10-29
JP2011519837A (ja) 2011-07-14
IL208765A0 (en) 2010-12-30
CA2720465A1 (en) 2009-10-29
EP2300493A2 (de) 2011-03-30
WO2009132209A3 (en) 2010-03-18

Similar Documents

Publication Publication Date Title
US8050871B2 (en) Method of predicting influenza outbreaks by correlating an increase in replikin count in shrimp white spot syndrome virus and/or taura syndrome virus
Medina et al. Influenza A viruses: new research developments
US20090017052A1 (en) Methods of determining lethality of pathogens and malignancies involving replikin peak genes
US20090269367A1 (en) Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
Yun et al. Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)
EP2027146B1 (de) Replikin-peptide und verwendungen davon
Hussein et al. Recent advances in hantavirus molecular biology and disease
AU2009240587A1 (en) Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
CA2759325A1 (en) Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
Tong Severe acute respiratory syndrome coronavirus (SARS-CoV)
RU2412244C1 (ru) ШТАММ ВИРУСА ГРИППА А/IIV-Moscow/01/2009 (H1N1)swl ДЛЯ РАЗРАБОТКИ СРЕДСТВ И МЕТОДОВ БИОЛОГИЧЕСКОЙ ЗАЩИТЫ
US20160122397A1 (en) Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
Jin et al. Pathogenesis of Emerging and Novel Bunyaviruses in Humans
KR20090094838A (ko) 레플리킨 피크 유전자와 관련된 병원체 및 악성 종양의 치사율 측정 방법
CN101688236A (zh) 确定包含Replikin Peak基因的病原体和恶性肿瘤的致死性的方法
Howard Lecture Notes On Emerging Viruses And Human Health: A Guide to Zoonotic Viruses and Their Impact
Evseenko et al. Pathogenesis of infectious disease of mice caused by H5N1 avian influenza virus
US20160114022A1 (en) Therapies, vaccines, and predictive methods for filoviruses including ebolavirus and marburg virus
Goedhals Immune responses to Crimean-Congo haemorrhagic fever virus and molecular characterization of viral isolates
KARIMI et al. Amino Acid Sequence Analysis of Hemagglutinin Protein of H9N2 Isolated from Broilers in Tehran in 2007
Yatsyshina et al. Isolation and molecular characterization of the influenza A/H5N1 viruses isolated during the outbreaks of avian influenza among birds in the European part of Russia in 2005: a virus strain with ozeltamivir-resistance mutation was found
Honigsbaum et al. Vietnam, February 2005

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application